LEADER 01327oam  2200409z- 450 
001 9910831044503321
005 19940524082411.6
010   $a1-68367-275-5
035   $a(CKB)4100000010871272
035   $a(EXLCZ)994100000010871272
100   $a20210811c2014uuuu  -u-            -
101 0 $aeng
200 00$aTuberculosis $epathogenesis, protection, and control /$feditor, Barry R. Bloom
210   $cJohn Wiley & Sons, Inc
311   $a1-55581-072-1 
311   $a1-119-73909-8 
517   $aTuberculosis 
606   $aTuberculosis
606   $aTuberculosis$xMolecular aspects
606   $aTuberculosis$xImmunological aspects
606   $aTuberculosis$xEpidemiology
606   $aTuberculosis$xpathology
606   $aTuberculosis$xprevention & control
606   $aMycobacterium tuberculosis$xpathogenicity
615  0$aTuberculosis.
615  0$aTuberculosis$xMolecular aspects.
615  0$aTuberculosis$xImmunological aspects.
615  0$aTuberculosis$xEpidemiology.
615  2$aTuberculosis$xpathology.
615  2$aTuberculosis$xprevention & control.
615  2$aMycobacterium tuberculosis$xpathogenicity.
676   $a616.9/95
701  0$aBloom$b Barry R.$f1937-$090073
906   $aBOOK
912   $a9910831044503321
996   $aTuberculosis$94121629
997   $aUNINA